Pitukkitronnagorn Nattapon, Chakkabat Chakkapong, Jittapiromsak Nutchawan
Division of Diagnostic Radiology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.
Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.
Neuroradiol J. 2025 Jan 7:19714009251313509. doi: 10.1177/19714009251313509.
Predicting treatment response in patients with vestibular schwannomas (VSs) remains challenging. This study aimed to evaluate the use of pre-treatment normalized apparent diffusion coefficient (nADC) values and magnetic resonance (MR) imaging characteristics in predicting treatment outcomes in patients with VSs undergoing radiosurgery.
The MR images of 44 patients with VSs who underwent radiosurgery at our institution were retrospectively reviewed, and the patients were categorized into tumor control ( = 28) and progression ( = 16) groups based on treatment response after treatment initiation, with a median follow-up duration of 29.5 (13-115) months. Pre-treatment nADC values for the whole tumor and solid portion of the tumor were assessed for predictive significance. MRI characteristics were analyzed, including hemorrhage status, tumor morphology, and post-treatment loss of central enhancement. Interobserver reliability was also evaluated.
Early post-treatment enlargement was associated with tumor progression ( = .024). The mean pre-treatment nADC values for the solid part of the tumor were significantly higher in the tumor control group than in tumor progression group (1.32 vs 1.05, = .005). The receiver operating characteristic curve analysis revealed a mean nADC of 1.18 as an optimal cutoff, with sensitivity and specificity of 76.2% and 86.7%, respectively, in predicting treatment response.
The mean nADC values for the solid part of the tumor demonstrated predictive value for treatment response, with implications for treatment planning. Notably, early post-treatment enlargement was correlated with tumor progression. Incorporating these findings into clinical practice may refine treatment strategies for patients with VSs undergoing radiosurgery.
预测前庭神经鞘瘤(VSs)患者的治疗反应仍然具有挑战性。本研究旨在评估治疗前标准化表观扩散系数(nADC)值和磁共振(MR)成像特征在预测接受放射外科治疗的VSs患者治疗结果中的应用。
回顾性分析了在我院接受放射外科治疗的44例VSs患者的MR图像,并根据治疗开始后的治疗反应将患者分为肿瘤控制组(n = 28)和进展组(n = 16),中位随访时间为29.5(13 - 115)个月。评估整个肿瘤和肿瘤实性部分的治疗前nADC值的预测意义。分析了MRI特征,包括出血状态、肿瘤形态和治疗后中心强化消失情况。还评估了观察者间的可靠性。
治疗后早期肿瘤增大与肿瘤进展相关(P = .024)。肿瘤控制组肿瘤实性部分的平均治疗前nADC值显著高于肿瘤进展组(1.32对1.05,P = .005)。受试者工作特征曲线分析显示,平均nADC为1.18作为最佳截断值,在预测治疗反应时敏感性和特异性分别为76.2%和86.7%。
肿瘤实性部分的平均nADC值对治疗反应具有预测价值,对治疗计划有指导意义。值得注意的是,治疗后早期肿瘤增大与肿瘤进展相关。将这些发现纳入临床实践可能会优化接受放射外科治疗的VSs患者的治疗策略。